Jon Saxe

Mr. Saxe holds a B.S. degree in Chemical Engineering from Carnegie-Mellon University and a J.D. from George Washington University School of Law. He also received an L.L.M. from New York University School of Law. He worked for Hoffmann-LaRoche Inc. from 1960 to 1989 where he rose to the position of Vice President of Licensing and Corporate Development, Head of Patent Law and Associate General Counsel. He served as the President and Chief Executive Officer of Synergen Inc. from 1989 to 1993 and as President of PDL Biopharma Inc. (formerly Protein Design Labs Inc.), a leader in the field of humanization of antibodies, from 1995 to 1999.

Mr. Saxe has been a Consultant in the fields of pharmaceuticals and biotechnology since 1999, including serving as Chairman of several companies (VistaGen Therapeutics, Iconix Pharmaceuticals, Lumos Pharma, SciClone Pharmaceuticals, Iconix Biosciences, Entelos, POINT Biomedical). He has been a Director of numerous additional companies, notably including: Incyte Genomics, Insite Vision, Questcor, Durect, and Sciele Pharmaceuticals.